# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ultomiris, the successor to Alexion Pharmaceuticals Inc's (NASDAQ: ALXN) paroxysmal nocturnal hemoglobinuria (PNH) drug Sol...
Moderna, Inc (NASDAQ: MRNA) gapped up 6.64% Friday morning after it was announced the company will join the S&P 500 beginni...
Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA), which ended Thursday's session with a market cap of $104.3...
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210715-1419561/1419561_5alxn.pdf
– Study met primary endpoint of change from baseline in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...
Before 10 a.m. ET Wednesday, 81 stocks made new 52-week highs.